EXHIBIT 5.1

                                                                  March 2_, 2006

Mazal Plant Pharmaceuticals Inc.
43 West 33rd Street
New York, NY 10001

            Re:   Registration Statement on Form SB-2

Ladies and Gentlemen:


We have  acted  as  counsel  for  Mazal  Plant  Pharmaceuticals  Inc,  a  Nevada
corporation (the "Company"),  in connection with the preparation of the recently
amended registration statement on Form SB-2 (the "Registration Statement") to be
filed with the Securities and Exchange Commission (the "Commission") pursuant to
the Securities Act of 1933, as amended (the "Act"),  relating to the offering by
the  Company  of up to  10,000,000  shares  of  common  stock  described  in the
Registration  Statement  ("Offering") and the registration for resale by certain
selling  security  holders of the  Company of up to  7,580,000  shares of common
stock in  connection  with the  registration  for resale of (a) up to  6,580,000
shares  of our  common  stock  and  (b) the  registration  for  resale  of up to
1,000,000  shares of our common  stock  which may be issued  upon  exercise of a
warrant that was issued in a transaction exempt from registration ( collectively
with the shares being offered in the Offering " the Shares").

      We have examined and are familiar with  originals or copies,  certified or
otherwise  identified to our  satisfaction,  of the Articles of Incorporation of
the Company,  the Company's Bylaws, the Registration  Statement,  resolutions of
the Board of Directors of the Company relating to the proposed  registration and
issuance  of the Shares and copies of such  other  agreements,  instruments  and
documents  as we have  deemed  necessary  to  enable us to  render  the  opinion
hereinafter  expressed and we have not examined nor reviewed any documents other
than those  specified  above,  nor have we  conducted  any  independent  factual
investigation in connection with this opinion.

      In our examination, we have assumed the genuineness of all signatures, the
legal  capacity  of all  natural  persons,  the  authenticity  of all  documents
submitted  to us as  originals,  the  conformity  to original  documents  of all
documents  submitted to us as copies,  the authenticity of the originals of such
latter  documents  and the  accuracy  and  completeness  of all  public  records
reviewed.  As to any facts material to the opinions  expressed herein which were
not  independently  established or verified,  we have relied upon statements and
representations of officers and other representatives of the Company and others.




      Based upon the foregoing,  we are of the opinion that the Shares of common
stock to be sold as part of the Offering described in the Registration Statement
will be,  when  issued in  accordance  with the terms of the  Offering,  validly
issued,  fully paid and  non-assessable  except as may be limited by bankruptcy,
insolvency, reorganization,  moratorium or similar laws relating to or affecting
creditors'  rights  generally   (including,   without   limitation,   fraudulent
conveyance  laws),  and by  general  principles  of  equity  including,  without
limitation, concepts of materiality, reasonableness, good faith and fair dealing
and the possible  unavailability of specific  performance or injunctive  relief,
regardless of whether considered in a proceeding in equity or at law.

      Based upon the foregoing,  we are of the opinion that the Shares of common
stock to be registered  for resale  pursuant to the  Registration  Statement are
validly  issued,  fully  paid and  non-assessable  except as may be  limited  by
bankruptcy, insolvency,  reorganization,  moratorium or similar laws relating to
or  affecting  creditors'  rights  generally  (including,   without  limitation,
fraudulent  conveyance  laws),  and by general  principles of equity  including,
without limitation, concepts of materiality, reasonableness, good faith and fair
dealing and the possible  unavailability  of specific  performance or injunctive
relief, regardless of whether considered in a proceeding in equity or at law.

      Based upon and subject to the  foregoing,  we are of the opinion  that the
Shares to be issued upon exercise of any options duly granted have been duly and
validly  authorized  and, when the Shares have been paid for in accordance  with
the terms of the warrant  agreement such Shares will be duly and validly issued,
fully  paid  and  non-assessable   except  as  may  be  limited  by  bankruptcy,
insolvency, reorganization,  moratorium or similar laws relating to or affecting
creditors'  rights  generally   (including,   without   limitation,   fraudulent
conveyance  laws),  and by  general  principles  of  equity  including,  without
limitation, concepts of materiality, reasonableness, good faith and fair dealing
and the possible  unavailability of specific  performance or injunctive  relief,
regardless of whether considered in a proceeding in equity or at law.

      We hereby  consent  to the  filing of this  opinion  as an  exhibit to the
Registration  Statement.  This opinion is  expressly  limited to the matters set
forth above and we render no opinion, whether by implication or otherwise, as to
any other matters.  We assume no obligation to update or supplement this opinion
to reflect any facts or circumstances  that arise after the date of this opinion
and come to our attention, or any future changes in law. In giving this consent,
we do not thereby  admit that we are in the category of persons whose consent is
required under Section 7 of the Securities Act, and the rules and regulations of
the Securities and Exchange Commission thereunder.



                                                      Very truly yours,


                                                      /s/ SR Kronengold